Stock SALV SALVARX GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart SalvaRx Group plc

Equities

SALV

IM00BZ4SS228

Delayed London S.E.
Other stock markets
 		5-day change 1st Jan Change
- GBX -.--% Intraday chart for SalvaRx Group plc -47.06% -.--%
2019 SalvaRx Evaluates Takeover Opportunities CI
2019 Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SALVARX GROUP PLC Stock SalvaRx Group plc
 2.16M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.22B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.02B -
  1. Stock Market
  2. Equities
  3. SALV Stock
  4. Charts SalvaRx Group plc
  5. Sector Chart